30 Participants Needed

PoNS Therapy for Stroke Survivors

Recruiting at 4 trial locations
MB
Overseen ByMark Bowden
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Helius Medical Inc
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Primary Objective: To further evaluate the aspects of safety related to PoNS therapy in chronic stroke survivors. Secondary Objectives: To further evaluate the efficacy of PoNS on improving dynamic gait and balance, establishing durability of effect, risk of falling and fall rate. As well as adherence to PoNS device utilization. Exploratory Objectives: To further evaluate quality of life to measure physical, mental, behavioral, and general health, as well as functional decline (\> 30% on gait or balance improvement at endpoint) during the 12-week follow-up.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, it does exclude participants using certain stimulation devices or those who have had neurostimulation therapy recently.

What data supports the effectiveness of the treatment PoNS Therapy for stroke survivors?

Research on neuromodulation techniques, like transcranial direct current stimulation (tDCS), shows promising results in helping stroke patients recover motor function. These techniques, which include PoNS Therapy, aim to stimulate the brain to improve movement and reduce disability after a stroke.12345

Is PoNS Therapy safe for humans?

The safety of PoNS Therapy, also known as Portable Neuromodulation Stimulator, has been evaluated in various studies, including those on vagus nerve stimulation (VNS) for stroke recovery. VNS, which is similar in its approach to neuromodulation, has been used safely in thousands of patients for conditions like seizures, suggesting a general safety profile for similar neuromodulation therapies.678910

How is PoNS Therapy different from other treatments for stroke recovery?

PoNS Therapy is unique because it uses a non-invasive device to stimulate the tongue, which is believed to help improve brain function and motor recovery in stroke survivors. This approach differs from traditional stroke treatments that often focus on physical rehabilitation or medications, as it directly targets the nervous system to enhance recovery.1231112

Eligibility Criteria

This trial is for chronic stroke survivors who are experiencing issues with walking and balance. Participants should be able to commit to the study duration and follow-up requirements. Specific eligibility details aren't provided, but typically, trials exclude individuals with conditions that could interfere with the treatment or skew results.

Inclusion Criteria

FGA score < 23 at screening
Able to understand, learn and apply instructions on how to operate the PoNS device and perform the rehabilitation exercise program
Montreal Cognitive Assessment 5-min (MoCA 5-min) ≥ 6
See 2 more

Exclusion Criteria

Pregnancy
I have undergone neurostimulation therapy in the last 6 months.
I have not received cancer treatment in the last year.
See 9 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment Part 1

Participants undergo DGB training in clinic supervised by the Trainer

4 weeks
Weekly visits (in-person)

Treatment Part 2

Participants continue DGB training at home, unsupervised, with weekly follow-ups

8 weeks
Weekly visits (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment, encouraged to continue physical rehabilitation

12 weeks
Final visit (in-person)

Treatment Details

Interventions

  • PoNS Therapy
Trial Overview The trial is testing PoNS Therapy—a device aimed at improving gait and balance in people who have had a stroke. The study will look at safety, how well it works for walking and balance, its lasting effects, fall risks, adherence to using the device, and overall quality of life.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
open label administration of translingual neurostimulation.

PoNS Therapy is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as PoNS for:
  • Gait deficit due to mild and moderate symptoms from stroke
  • Chronic balance deficit due to mild-to-moderate traumatic brain injury

Find a Clinic Near You

Who Is Running the Clinical Trial?

Helius Medical Inc

Lead Sponsor

Trials
10
Recruited
370+

Antonella Favit-VanPelt

Lead Sponsor

Trials
1
Recruited
30+

Findings from Research

Neuromodulation techniques like repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) show promise for enhancing motor recovery in stroke patients, with some studies indicating definite efficacy for low-frequency rTMS in improving hand motor recovery during the post-acute stage.
Adjunctive vagal nerve stimulation has received FDA approval for improving upper limb motor recovery in chronic ischemic stroke patients, highlighting the potential of neuromodulation as a valuable addition to standard rehabilitation therapies.
Neuromodulation for Post-Stroke Motor Recovery: a Narrative Review of Invasive and Non‑Invasive Tools.Keser, Z., Ikramuddin, S., Shekhar, S., et al.[2023]
Transcranial direct current stimulation (tDCS) is a promising neuromodulation therapy that may help improve outcomes in stroke patients, who face significant challenges in recovery and rehabilitation.
Despite the potential of neuromodulation therapies like tDCS, the mechanisms of stroke recovery and the effectiveness of rehabilitation strategies are not fully understood, highlighting the need for further research in this area.
The effect of transcranial direct current stimulation combined with functional task training on motor recovery in stroke patients.Alsharidah, M., Al-Hussain, F., Iqbal, M., et al.[2019]
Deep brain stimulation (DBS) shows promise in managing post-stroke maladaptive responses such as pain, dystonia, dyskinesias, and tremor, based on a comprehensive literature review.
While evidence for DBS improving motor deficits after stroke is limited, some studies suggest that targeting the posterior limb of the internal capsule may help improve weakness (paresis) in certain cases, indicating a need for further research in this area.
Deep brain stimulation for stroke: Current uses and future directions.Elias, GJB., Namasivayam, AA., Lozano, AM.[2018]

References

Neuromodulation for Post-Stroke Motor Recovery: a Narrative Review of Invasive and Non‑Invasive Tools. [2023]
The effect of transcranial direct current stimulation combined with functional task training on motor recovery in stroke patients. [2019]
Deep brain stimulation for stroke: Current uses and future directions. [2018]
Effect of transcutaneous electrical nerve stimulation (TENS) on Barthel Activities of Daily Living (ADL) index score following stroke. [2022]
Low-Frequency Brain Oscillations Track Motor Recovery in Human Stroke. [2020]
Non-invasive brain stimulation as therapeutic approach for ischemic stroke: Insights into the (sub)cellular mechanisms. [2022]
Efficacy and Safety of Vagus Nerve Stimulation on Upper Limb Motor Recovery After Stroke. A Systematic Review and Meta-Analysis. [2022]
tVNS in Stroke: A Narrative Review on the Current State and the Future. [2023]
Vagus nerve stimulation therapy summary: five years after FDA approval. [2022]
Effects and safety of vagus nerve stimulation on upper limb function in patients with stroke: a systematic review and meta-analysis. [2023]
Advances in Stroke Neurorehabilitation. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Emerging treatments for motor rehabilitation after stroke. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security